Th17 Cells and the IL-23/IL-17 Axis in the Pathogenesis of Periodontitis and Immune-Mediated Inflammatory Diseases

IL-17 and IL-22 promote keratinocyte stemness in the germinative compartment in psoriasis

(2019) Anna-Karin Ekman et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Greater cumulative benefits from ixekizumab versus ustekinumab treatment over 52 weeks for patients with moderate-to-severe psoriasis in a randomized, double-blinded phase 3b clinical trial

(2019) Andrew Blauvelt et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Brodalumab for the treatment of plaque psoriasis: up-to-date

(2019) Kristen M. Beck et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs

(2019) Subrata Ghosh et al.   DRUG SAFETY

Guselkumab for the Treatment of Psoriasis

(2018) Álvaro Machado et al.   BIODRUGS

Autoimmunity and autoimmune co-morbidities in psoriasis

(2018) Kazuhisa Furue et al.   IMMUNOLOGY

Increased risk of periodontitis among patients with Crohn’s disease: a population-based matched-cohort study

(2018) Ying-Chen Chi et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

Th17 cells, γδ T cells and their interplay in EAE and multiple sclerosis

(2018) Aoife M. McGinley et al.   JOURNAL OF AUTOIMMUNITY

A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasis

(2018) Jawad Bilal et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Shifting the focus - the primary role of IL-23 in psoriasis and other inflammatory disorders

(2018) M.J. Gooderham et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Interleukin-17 family cytokines in protective immunity against infections: role of hematopoietic cell-derived and non-hematopoietic cell-derived interleukin-17s

(2018) Goro Matsuzaki et al.   MICROBIOLOGY AND IMMUNOLOGY

Relationship between sjögren syndrome and periodontal status: A systematic review

(2018) Luana de Goés Soares et al.   Oral Surgery Oral Medicine Oral Pathology Oral Radiology

Ixekizumab: A Review of Its Use for the Management of Moderate to Severe Plaque Psoriasis

(2018) Sydney K. Shelton et al.   ANNALS OF PHARMACOTHERAPY

Tildrakizumab: A Review of Phase II and III Clinical Trials

(2018) Sree S. Kolli et al.   ANNALS OF PHARMACOTHERAPY

The Oral Microbiota Is Modified by Systemic Diseases

(2018) D.T. Graves et al.   JOURNAL OF DENTAL RESEARCH

Periodontitis as another comorbidity associated with psoriasis: A case-control study

(2018) Victor Silva Mendes et al.   JOURNAL OF PERIODONTOLOGY

Primary Sjögren's syndrome

(2018) SJ Bowman   LUPUS

Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon

(2018) Alessio Mylonas et al.   Frontiers in Immunology

Th22 Cells Promote Osteoclast Differentiation via Production of IL-22 in Rheumatoid Arthritis

(2018) Yusuke Miyazaki et al.   Frontiers in Immunology

Pre-diagnostic genotyping identifies T1D subjects with impaired Treg IL-2 signaling and an elevated proportion of FOXP3+IL-17+ cells

(2017) A K Marwaha et al.   GENES AND IMMUNITY

On-going Mechanical Damage from Mastication Drives Homeostatic Th17 Cell Responses at the Oral Barrier

(2017) Nicolas Dutzan et al.   IMMUNITY

Immunopathogenesis of Rheumatoid Arthritis

(2017) Gary S. Firestein et al.   IMMUNITY

Fibroblast-like synoviocytes-dependent effector molecules as a critical mediator for rheumatoid arthritis: Current status and future directions

(2017) Ramamoorthi Ganesan et al.   INTERNATIONAL REVIEWS OF IMMUNOLOGY

Inflammatory bowel disease and oral health: systematic review and a meta-analysis

(2017) Spyridon N. Papageorgiou et al.   JOURNAL OF CLINICAL PERIODONTOLOGY

Review of IL-17 inhibitors for psoriasis

(2017) Mina Amin et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Increased levels of the T-helper 22-associated cytokine (interleukin-22) and transcription factor (aryl hydrocarbon receptor) in patients with periodontitis are associated with osteoclast resorptive activity and severity of the disease

(2017) J. Díaz-Zúñiga et al.   JOURNAL OF PERIODONTAL RESEARCH

Psoriasis and comorbid diseases

(2017) Junko Takeshita et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Tumor necrosis factor-α inhibitor-induced psoriasis: Systematic review of clinical features, histopathological findings, and management experience

(2017) Gabrielle Brown et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Crohn Disease: Epidemiology, Diagnosis, and Management

(2017) Joseph D. Feuerstein et al.   MAYO CLINIC PROCEEDINGS

Cytokine Imbalance as a Common Mechanism in Both Psoriasis and Rheumatoid Arthritis

(2017) Yong Tan et al.   MEDIATORS OF INFLAMMATION

Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders

(2017) Patrizia Fasching et al.   MOLECULES

Immunogenicity and loss of response to TNF inhibitors: implications for rheumatoid arthritis treatment

(2017) Joachim R. Kalden et al.   Nature Reviews Rheumatology

Interleukin-12 and Interleukin-23 Blockade in Leukocyte Adhesion Deficiency Type 1

(2017) Niki M. Moutsopoulos et al.   NEW ENGLAND JOURNAL OF MEDICINE

Association between a history of periodontitis and the risk of systemic lupus erythematosus in Taiwan: A nationwide, population-based, case-control study

(2017) Yi-Da Wu et al.   PLoS One

Cellular and molecular perspectives in rheumatoid arthritis

(2017) Douglas J. Veale et al.   Seminars in Immunopathology

Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective

(2017) Vaishali R. Moulton et al.   TRENDS IN MOLECULAR MEDICINE

Effects of periodontal treatment on primary sjȫgren’s syndrome symptoms

(2017) Lucas Macedo Batitucci AMBRÓSIO et al.   Brazilian Oral Research

Secukinumab in Active Rheumatoid Arthritis: A Phase III Randomized, Double-Blind, Active Comparator- and Placebo-Controlled Study

(2017) Francisco J. Blanco et al.   Arthritis & Rheumatology

Levels of peripheral Th17 cells and serum Th17-related cytokines in patients with multiple sclerosis: A meta-analysis

(2017) Yu-Feng Li et al.   Multiple Sclerosis and Related Disorders

T Helper 17 Cells in Primary Sjögren’s Syndrome

(2017) Kiyoshi Matsui et al.   Journal of Clinical Medicine

Periodontitis increases rheumatic factor serum levels and citrullinated proteins in gingival tissues and alter cytokine balance in arthritic rats

(2017) Mônica G. Corrêa et al.   PLoS One

Gastrointestinal diseases and their oro-dental manifestations: Part 1: Crohn's disease

(2016) C. X. W. Tan et al.   BRITISH DENTAL JOURNAL

Circulating T-helper 17 cells and associated cytokines in psoriasis

(2016) S. Chhabra et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY

The immune system

(2016) L. B. Nicholson   Essays in Biochemistry

Innate immunity in vertebrates: an overview

(2016) Mario Riera Romo et al.   IMMUNOLOGY

CD4+T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm

(2016) Kiyoshi Hirahara et al.   INTERNATIONAL IMMUNOLOGY

Periodontitis prevalence and serum antibody reactivity to periodontal bacteria in primary Sjögren's syndrome: a pilot study

(2016) Bozo Lugonja et al.   JOURNAL OF CLINICAL PERIODONTOLOGY

Mechanism of Action of Anti-TNF Therapy in Inflammatory Bowel Disease

(2016) Alon D. Levin et al.   Journal of Crohns & Colitis

Risk of periodontitis in patients with psoriasis and psoriatic arthritis

(2016) A. Egeberg et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-α in early phases of the disease

(2016) Giacomo Emmi et al.   MEDICINE

Role of bacteria in leukocyte adhesion deficiency-associated periodontitis

(2016) George Hajishengallis et al.   MICROBIAL PATHOGENESIS

TFH cells progressively differentiate to regulate the germinal center response

(2016) Jason S Weinstein et al.   NATURE IMMUNOLOGY

IL-17: overview and role in oral immunity and microbiome

(2016) L Abusleme et al.   ORAL DISEASES

Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials

(2016) Sumit Kunwar et al.   RHEUMATOLOGY INTERNATIONAL

Periodontal and inflammatory bowel diseases: Is there evidence of complex pathogenic interactions?

(2016) Ronaldo Lira-Junior et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Cytokines IL-17 and IL-22 in the host response to infection

(2016) Maria Valeri et al.   Pathogens and Disease

Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture

(2015) Philip E. Stuart et al.   AMERICAN JOURNAL OF HUMAN GENETICS

The interleukin (IL)-23/IL-17 axis in ankylosing spondylitis: new advances and potentials for treatment

(2015) H. Jethwa et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Role of IL-17 in the pathogenesis of psoriatic arthritis and axial spondyloarthritis

(2015) Smriti K Raychaudhuri et al.   CLINICAL RHEUMATOLOGY

Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis

(2015) Philip J. Mease   CURRENT OPINION IN RHEUMATOLOGY

An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17

(2015) Lynda Grine et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Safety and Efficacy of Open-label Subcutaneous Ixekizumab Treatment for 48 Weeks in a Phase II Study in Biologic-naive and TNF-IR Patients with Rheumatoid Arthritis

(2015) Mark C. Genovese et al.   JOURNAL OF RHEUMATOLOGY

Psoriasis

(2015) Wolf-Henning Boehncke et al.   LANCET

Harnessing the Therapeutic Potential of Th17 Cells

(2015) Jonas Bystrom et al.   MEDIATORS OF INFLAMMATION

Periodontal Diseases and Dental Caries in Children with Type 1 Diabetes Mellitus

(2015) Marta Novotna et al.   MEDIATORS OF INFLAMMATION

Basic biology and role of interleukin-17 in immunity and inflammation

(2015) Camille Zenobia et al.   PERIODONTOLOGY 2000

Regulation of IL-17 in autoimmune diseases by transcriptional factors and microRNAs

(2015) Deena Khan et al.   Frontiers in Genetics

Diagnosis and classification of psoriasis

(2014) Smriti K. Raychaudhuri et al.   AUTOIMMUNITY REVIEWS

Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus

(2014) Jérôme C. Martin et al.   CLINICAL IMMUNOLOGY

Periodontitis treatment improves systemic lupus erythematosus response to immunosuppressive therapy

(2014) Cristiana Fabbri et al.   CLINICAL RHEUMATOLOGY

Advances in the understanding and treatment of systemic complications in Sjögrenʼs syndrome

(2014) Pilar Brito-Zerón et al.   CURRENT OPINION IN RHEUMATOLOGY

No association between multiple sclerosis and periodontitis after adjusting for smoking habits

(2014) M. W. Gustavsen et al.   EUROPEAN JOURNAL OF NEUROLOGY

Psoriasis is not an autoimmune disease?

(2014) Lionel Fry et al.   EXPERIMENTAL DERMATOLOGY

Dendritic cells, T-cells and epithelial cells: a crucial interplay in immunopathology of primary Sjögren's syndrome

(2014) Maarten R Hillen et al.   Expert Review of Clinical Immunology

Etiology of leukocyte adhesion deficiency-associated periodontitis revisited: not a raging infection but a raging inflammatory response

(2014) George Hajishengallis et al.   Expert Review of Clinical Immunology

Erratum to: Clinical associations between IL-17 family cytokines and periodontitis and potential differential roles for IL-17A and IL-17E in periodontal immunity

(2014) Raja Azman Awang et al.   INFLAMMATION RESEARCH

The presence, function and regulation of IL-17 and Th17 cells in periodontitis

(2014) Wan-Chien Cheng et al.   JOURNAL OF CLINICAL PERIODONTOLOGY

Association of chronic periodontitis and psoriasis: periodontal status with severity of psoriasis

(2014) A Sharma et al.   ORAL DISEASES

Smoking as a Permissive Factor of Periodontal Disease in Psoriasis

(2014) Márk Antal et al.   PLoS One

Risk of tuberculosis in patients with chronic immune-mediated inflammatory diseases treated with biologics and tofacitinib: a systematic review and meta-analysis of randomized controlled trials and long-term extension studies

(2014) Alejandro Souto et al.   RHEUMATOLOGY

Defective Neutrophil Recruitment in Leukocyte Adhesion Deficiency Type I Disease Causes Local IL-17-Driven Inflammatory Bone Loss

(2014) N. M. Moutsopoulos et al.   Science Translational Medicine

Targeting Th17 cells in autoimmune diseases

(2014) Jianfei Yang et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Inflammatory bowel disease: Pathogenesis

(2014) Yi-Zhen Zhang   WORLD JOURNAL OF GASTROENTEROLOGY

Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?

(2014) Lisa GM van Baarsen et al.   ARTHRITIS RESEARCH & THERAPY

Genetic dysbiosis: the role of microbial insults in chronic inflammatory diseases

(2014) Luigi Nibali et al.   Journal of Oral Microbiology

Predominantly proinflammatory cytokines decrease after B cell depletion therapy in patients with primary Sjögren's syndrome

(2013) R P E Pollard et al.   ANNALS OF THE RHEUMATIC DISEASES

IL-17/Th17 mediated synovial inflammation is IL-22 independent

(2013) Jan Piet van Hamburg et al.   ANNALS OF THE RHEUMATIC DISEASES

Th17 and Treg Cells in Bone Related Diseases

(2013) Min Wang et al.   Clinical & Developmental Immunology

Th17 Cells in Immunity and Autoimmunity

(2013) Simone Kennedy Bedoya et al.   Clinical & Developmental Immunology

Association between multiple sclerosis and chronic periodontitis: a population-based pilot study

(2013) J.-J. Sheu et al.   EUROPEAN JOURNAL OF NEUROLOGY

Recent advances in understanding the molecular mechanisms of the development and function of Th17 cells

(2013) Yutaka Kurebayashi et al.   GENES TO CELLS

Risk Factors and Primary Prevention Trials for Type 1 Diabetes

(2013) Yan-Ling Wu et al.   International Journal of Biological Sciences

Periodontitis and Etanercept Discontinuation Risk in Anti–Tumor Necrosis Factor–Naive Rheumatoid Arthritis Patients

(2013) Hsin-Hua Chen et al.   JCR-JOURNAL OF CLINICAL RHEUMATOLOGY

High Intestinal and Systemic Levels of Interleukin-23/T-Helper 17 Pathway in Chinese Patients with Inflammatory Bowel Disease

(2013) Lu Song et al.   MEDIATORS OF INFLAMMATION

Genetics and epigenetics of rheumatoid arthritis

(2013) Sebastien Viatte et al.   Nature Reviews Rheumatology

Inflammatory and immune pathways in the pathogenesis of periodontal disease

(2013) Ali Cekici et al.   PERIODONTOLOGY 2000

Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway

(2012) Saba Alzabin et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study

(2012) Mark C Genovese et al.   ANNALS OF THE RHEUMATIC DISEASES

The effects of chronic periodontitis and its treatment on the subsequent risk of psoriasis

(2012) J.J. Keller et al.   BRITISH JOURNAL OF DERMATOLOGY

A Validated Regulatory Network for Th17 Cell Specification

(2012) Maria Ciofani et al.   CELL

A Role for Epigenetics in Psoriasis: Methylated Cytosine–Guanine Sites Differentiate Lesional from Nonlesional Skin and from Normal Skin

(2012) Johann E. Gudjonsson et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Signs of the presence of Th17 cells in chronic periodontal disease

(2012) M. Adibrad et al.   JOURNAL OF PERIODONTAL RESEARCH

The association of psoriasis with autoimmune diseases

(2012) Jashin J. Wu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Association of chronic plaque psoriasis and severe periodontitis: a hospital based case-control study

(2012) E. Lazaridou et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Ulcerative colitis

(2012) Ingrid Ordás et al.   LANCET

Crohn's disease

(2012) Daniel C Baumgart et al.   LANCET

Induction and molecular signature of pathogenic TH17 cells

(2012) Youjin Lee et al.   NATURE IMMUNOLOGY

Anti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis

(2012) Craig Leonardi et al.   NEW ENGLAND JOURNAL OF MEDICINE

TLR2 ligation induces the production of IL-23/IL-17 via IL-6, STAT3 and NF-kB pathway in patients with primary Sjogren's syndrome

(2012) Seung-Ki Kwok et al.   ARTHRITIS RESEARCH & THERAPY

Periodontitis and diabetes: a two-way relationship

(2011) P. M. Preshaw et al.   DIABETOLOGIA

The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases

(2011) Rajita Pappu et al.   IMMUNOLOGY

Life before Seventeen: Cloning of the IL-17 Receptor

(2011) S. L. Gaffen   JOURNAL OF IMMUNOLOGY

Fate mapping of IL-17-producing T cells in inflammatory responses

(2011) Keiji Hirota et al.   NATURE IMMUNOLOGY

Human TH17 Cells Are Long-Lived Effector Memory Cells

(2011) I. Kryczek et al.   Science Translational Medicine

Differentiation of Effector CD4 T Cell Populations

(2010) Jinfang Zhu et al.   Annual Review of Immunology

The increased mucosal mRNA expressions of complement C3 and interleukin-17 in inflammatory bowel disease

(2010) T. Sugihara et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Genome-wide Profiling of Interleukin-4 and STAT6 Transcription Factor Regulation of Human Th2 Cell Programming

(2010) Laura L. Elo et al.   IMMUNITY

IL-17 in Sera from Patients with Aggressive Periodontitis

(2010) H.A. Schenkein et al.   JOURNAL OF DENTAL RESEARCH

IL-17 Immunity in Human Type 1 Diabetes

(2010) J. Honkanen et al.   JOURNAL OF IMMUNOLOGY

Genetics, pathogenesis and clinical interventions in type 1 diabetes

(2010) Jeffrey A. Bluestone et al.   NATURE

Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis

(2010) Christopher E.M. Griffiths et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral biofilm-associated diseases: trends and implications for quality of life, systemic health and expenditures

(2010) Thomas Beikler et al.   PERIODONTOLOGY 2000

Epidemiologic patterns of chronic and aggressive periodontitis

(2010) Ryan T. Demmer et al.   PERIODONTOLOGY 2000

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

(2010) W. Hueber et al.   Science Translational Medicine

Systemic and Local Interleukin-17 and Linked Cytokines Associated with Sjögren’s Syndrome Immunopathogenesis

(2009) Gikas E. Katsifis et al.   AMERICAN JOURNAL OF PATHOLOGY

Inhibition of Th17 Cells Regulates Autoimmune Diabetes in NOD Mice

(2009) J. A. Emamaullee et al.   DIABETES

Diseases that may benefit from manipulating the Th17 pathway

(2009) Pierre Miossec   EUROPEAN JOURNAL OF IMMUNOLOGY

Over-expression of forkhead box P3 and its association with receptor activator of nuclear factor-κB ligand, interleukin (IL) -17, IL-10 and transforming growth factor-βduring the progression of chronic periodontitis

(2009) Nicolás Dutzan et al.   JOURNAL OF CLINICAL PERIODONTOLOGY

A New Inflammatory Cytokine on the Block: Re-thinking Periodontal Disease and the Th1/Th2 Paradigm in the Context of Th17 Cells and IL-17

(2009) S.L. Gaffen et al.   JOURNAL OF DENTAL RESEARCH

The IL-23/Th17 Axis in the Immunopathogenesis of Psoriasis

(2009) Antonella Di Cesare et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice

(2008) Reiko Ito et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease

(2008) T Kobayashi et al.   GUT

T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ

(2008) Xuexian O. Yang et al.   IMMUNITY

Antibody responses to Porphyromonas gingivalis (P. gingivalis) in subjects with rheumatoid arthritis and periodontitis

(2008) Ted R. Mikuls et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Foxp3 Inhibits RORγt-mediatedIL-17AmRNA Transcription through Direct Interaction with RORγt

(2008) Kenji Ichiyama et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Prevalence of periodontitis and DMFT index in patients with Crohn's disease and ulcerative colitis

(2008) Fernanda Brito et al.   JOURNAL OF CLINICAL PERIODONTOLOGY

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

(2008) Craig L Leonardi et al.   LANCET

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

(2008) Kim A Papp et al.   LANCET

Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease

(2008) C. R. Cardoso et al.   Oral microbiology and immunology

Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohnʼs disease and analysis of the IL17F p.His161Arg polymorphism in IBD

(2007) Julia Seiderer et al.   INFLAMMATORY BOWEL DISEASES